Product Name: Disomotide
CAS No: 181477-43-0
Purity: 95%
Molar Mass: 1035.21
Chemical Formula: C47H74N10O14S
Synonyms: G209-2M, MPS 22
Storage: Store at -20℃
Sequence: IMDQVPFSV
Application: Disomotide (CAS: 181477-43-0) is a synthetic peptide-based compound currently under investigation for its potential therapeutic applications in cancer treatment. It functions as an immunomodulator by targeting toll-like receptor 7 (TLR7), a pattern recognition receptor involved in the innate immune response. Disomotide activates TLR7, leading to the production of pro-inflammatory cytokines and chemokines, as well as the activation of antigen-presenting cells and cytotoxic T cells. This immune activation helps to enhance anti-tumor immune responses and modulate the tumor microenvironment, promoting tumor cell death and inhibiting tumor growth and metastasis. In pharmaceutical chemistry, disomotide’s targeted modulation of TLR7 represents a novel approach to cancer immunotherapy, offering potential benefits in the treatment of various cancers. Clinical trials are underway to evaluate its safety, efficacy, and therapeutic potential in different cancer types, with the goal of providing new treatment options for patients with advanced or metastatic disease.
